Over 2.24 lakh beneficiaries given COVID-19 vaccine so far; 447 cases of adverse effect reported: Govt

2,07,229 received jabs on day one of the drive

Over 2.24 lakh beneficiaries given COVID-19 vaccine so far; 447 cases of adverse effect reported: Govt

A medic shows a Covishield vaccine vial, after the virtual launch of COVID-19 vaccination drive by Prime Minister Narendra Modi, at Government Girls School in Gurugram. PTI

New Delhi, January 17

A total of 2,24,301 beneficiaries have been inoculated with COVID-19 vaccine so far, out of which only 447 adverse events following immunisation (AEFI) were reported, the Union Health Ministry said on day two of the nationwide vaccination drive on Sunday.

Addressing a press briefing, the ministry’s Additional Secretary Manohar Agnani said out of the 447 adverse events following immunisation, only three required hospitalisation.

“Today being Sunday, only six states conducted vaccination drive and in 553 sessions a total of 17,072 beneficiaries were vaccinated,” he said.

The six states where the vaccination drive was carried out on Sunday are Andhra Pradesh, Arunachal Pradesh, Karnataka, Kerala, Manipur and Tamil Nadu, he added.

Agnani said a total of 2,24,301 beneficiaries have been vaccinated till January 17 as per provisional reports, adding that 2,07,229 of them received the jabs on day one of the drive.

“A total of 447 AEFI have been reported on January 16 and 17, out of which only three required hospitalisation. Most of the AEFI reported so far are minor like fever, headache, nausea,” he said.

He said a meeting was held with all states and union territories on Sunday to review the progress of the drive, identify bottlenecks and plan corrective actions.

Prime Minister Narendra Modi rolled out the world’s largest inoculation drive against COVID-19 on Saturday and said the two vaccines being deployed will ensure a “decisive victory” for India against the pandemic.

India has approved two vaccines—Covaxin developed by Bharat Biotech and Covishield from the Oxford/AstraZeneca stable being manufactured by the Serum Institute of India—for emergency use in the country.

According to the government, the shots will be offered first to an estimated one crore healthcare workers and around two crore frontline workers, and then to persons above 50 years of age, followed by persons younger than 50 years of age with associated comorbidities. PTI

Top Stories

India reports 16,738 new Covid cases, highest since January 29

India reports 16,738 new Covid cases, highest since January 29

The daily deaths were registered above 130 after a gap of 26...

Biden revokes Trump ban on many green card applicants

Biden revokes Trump ban on many green card applicants

Former President issued ban last year

Kidnapping claim of Navy man who was ‘burnt alive’ seems to be fiction: Police

Kidnapping claim of Navy man who was ‘burnt alive’ seems to be fiction: Police

Dube incurred heavy losses in stock market, run up huge debt...

India searching for Rohingya adrift without food, water: UN

India searching for Rohingya adrift without food, water: UN

The boat was believed to have left Bangladesh two weeks ago ...

Neera Tanden’s confirmation vote gets delayed, White House says ‘fighting’ for her nomination

Neera Tanden’s confirmation vote gets delayed, White House says ‘fighting’ for her nomination

Speculation was rife that the White House is struggling to g...

Cities

View All